Silence Therapeutics plc Net Income Loss

• Silence Therapeutics plc showed a decrease of -95.6% in Net Income Loss from 2024 to 2025.
• This data is from Silence Therapeutics plc's annual report (Form 10-K), filed with the SEC on March 5, 2026.
• XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 4 years of available data (2022 to 2025), Silence Therapeutics plc's Net Income Loss has declined by 76.0%.
• Historical annual values: Fiscal year 2025: -$88.61 million | Fiscal year 2024: -$45.31 million | Fiscal year 2023: -$54.23 million | Fiscal year 2022: -$50.33 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026